Plasmodium vivax vaccine research – we’ve only just begun

• Blood-stage vaccine development is particularly critical for Plasmodium vivax.
• Large-scale protein arrays are powering an expansion in vaccine antigen screening.
• Structural studies allow antigen design to focus on critical pan-reactive epitopes.
• Further information on immune mechanisms and antigen diversity is needed.